(Q40950317)

25 September 2017

1 reference

title

Metastases of unknown primary site (English)

1 reference

25 September 2017

Lembersky BC

1

1 reference

25 September 2017

Thomas LC

series ordinal

2

1 reference

25 September 2017

publication date

1 January 1996

1 reference

Medical Clinics of North America

25 September 2017

published in

1 reference

25 September 2017

volume

80

1 reference

25 September 2017

issue

1

1 reference

25 September 2017

page(s)

153-171

1 reference

Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

VAC (vincristine, adriamycin, cyclophosphamide) chemotherapy for metastatic carcinoma from an unknown primary site.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Chromosome 1 aberrations in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Occult breast cancer presenting with axillary metastases. Updated management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Hormone receptor studies in axillary metastases from occult breast cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Guidelines for radiotherapeutic techniques for cervical metastases from an unknown primary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Peritoneal papillary serous carcinoma with long-term survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Metastases to lymph nodes of the head and neck from an unknown primary site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Adjuvant tamoxifen treatment of elderly women with stage II breast cancer. A double-blind comparison with placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

7 January 2021

Unknown primary tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Metastatic squamous cell carcinoma of an unknown primary localized to the neck. Advantages of an aggressive treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Metastatic carcinomas from occult primary tumors. A study of 254 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Disseminated prostatic carcinoma simulating primary lung cancer. Indications for immunodiagnostic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

5-fluorouracil, adriamycin, and mitomycin in the treatment of adenocarcinoma of unknown primary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

7 January 2021

Tumors of unknown origin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Metastatic inguinal nodes from an unknown primary neoplasm. A review of 56 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Treatment of patients with cancer of an unknown primary site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Poorly differentiated carcinoma of unknown primary site: clinical usefulness of immunoperoxidase staining

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Current status of adjuvant systemic therapy for primary breast cancer: progress and controversy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Cisplatin and 5-fluorouracil as induction chemotherapy followed by radiation therapy in metastatic squamous cell carcinoma of an unknown primary tumor localized to the neck. A phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Computed tomography in search of cancer of unknown origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

A phase II trial of biochemical modulation using N-phosphonacetyl-L-aspartate, high-dose methotrexate, high-dose 5-fluorouracil, and leucovorin in patients with adenocarcinoma of unknown primary site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Metastatic adenocarcinoma to the neck from an unknown primary source

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Cervical metastases from unknown primaries: radiotherapeutic management and appearance of subsequent primaries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Neoplasms of unknown primary site: a clinicopathological study of autopsied patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Computed tomography in the evaluation of metastatic adenocarcinoma from an unknown primary site. A retrospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Metastatic adenocarcinoma of unknown primary site. A randomized study of two combination chemotherapy regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Axillary lymph node metastasis from an occult breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Evaluation of six tumor markers in patients with carcinoma of unknown primary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Continuous infusion 5-fluorouracil, etoposide and cis-diamminedichloroplatinum in patients with metastatic carcinoma of unknown primary origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Papillary serous carcinoma of the peritoneum. A review of 33 cases treated with platin-based chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Axillary lymph node metastases in patients with occult noninvasive breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Cervical node metastasis of occult origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Empiric chemotherapy in patients with carcinoma of unknown primary site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Diagnostic persistence in working up metastatic cancer with an unknown primary site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Unknown primary adenocarcinoma: incidence of overinvestigation and natural history

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Peritoneal carcinomatosis of unknown primary site in women. A distinctive subset of adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Simple prognostic model to predict survival in patients with undifferentiated carcinoma of unknown primary site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Chemotherapy as treatment of choice in extrapulmonary undifferentiated small cell carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Metastatic adenocarcinomas of unknown primary site: a randomized study of two combination-chemotherapy regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

7 January 2021

Inguinal node metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

Leuprolide with and without flutamide in advanced prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970433-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7125(05)70433-8

1 reference

25 September 2017

1 reference